Edinburgh Biosciences Ltd focuses on developing innovative biotechnological solutions aimed at addressing critical challenges in healthcare and life sciences. The company leverages advanced methodologies in drug discovery and development, utilizing cutting-edge techniques to enhance the efficacy and safety of therapeutic agents. Their pipeline includes a range of products that target various diseases, showcasing their commitment to translating scientific research into practical applications that can improve patient outcomes.

The technologies employed by Edinburgh Biosciences Ltd encompass a variety of platforms, including high-throughput screening, molecular biology techniques, and bioinformatics. These tools enable the company to identify and optimize potential drug candidates efficiently. Additionally, their research emphasizes the importance of collaboration with academic institutions and industry partners, fostering an environment of innovation that accelerates the development of novel therapies and contributes to the advancement of biomedical science.

United Kingdom

The world's first non-invasive solution to treat and reverse cataracts. Our scientists have been working to develop a completely novel therapeutic approach to the treatment of cataracts based on the use of light rather than surgery or drugs. Cataracts develop slowly over many years and the gradual changes often go unnoticed at first. LEDINBIO uses light energy with specific wavelengths to reform the proteins in your eye which allows light to pass through allowing you to see clearly and brightly once again.

3 Michaelson Square, Suite 1b, Kirkton Campus, Livingston, Scotland EH54 7DP, GB

Edinburgh Biosciences Ltd

Company Details